Plasma ADMA associates with all-cause mortality in renal transplant recipients

Asymmetric dimethylarginine (ADMA) is a key endogenous inhibitor of endothelial NO synthase that affects endothelial function, blood pressure and vascular remodeling. Increased plasma levels of ADMA are associated with worse outcome from cardiovascular disease. Due to endothelial dysfunction before...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Amino Acids
Autors principals: Frenay, Anne-Roos S., van den Berg, Else, de Borst, Martin H., Beckmann, Bibiana, Tsikas, Dimitrios, Feelisch, Martin, Navis, Gerjan, Bakker, Stephan J. L., van Goor, Harry
Format: Artigo
Idioma:Inglês
Publicat: Springer Vienna 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549386/
https://ncbi.nlm.nih.gov/pubmed/26077715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00726-015-2023-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars